TET2, ANPM1 and FLT3-ITD Gene Mutations in Normal Karyotype Acute Myeloid Leukemia

被引：0
|
作者：
Sun, Aining [1 ]
Tian, Xiaopeng [1 ]
Yin, Jia [1 ]
Li, Weiyang [1 ]
Chen, Suning [1 ]
Wu Depei [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou, Peoples R China
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1413.1413
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1413
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells
    Liu, Xiao-Jian
    Wang, Li-Na
    Zhang, Zu-Han
    Liang, Cong
    Li, Yu
    Luo, Jie-Si
    Peng, Chun-Jin
    Zhang, Xiao-Li
    Ke, Zhi-Yong
    Huang, Li-Bin
    Tang, Yan-Lai
    Luo, Xue-Qun
    JOURNAL OF CANCER, 2020, 11 (12): : 3476 - 3482
  • [42] A COMPARATIVE STUDY OF VARIOUS FLT3-ITD MUTATIONS ISOLATED FROM ACUTE MYELOID LEUKEMIA PATIENTS
    Nordigarden, Amanda
    Halvarsson, Camilla
    Tang, Yanjuan
    Druid, Pia
    Jonsson, Jan-Ingvar
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S130 - S131
  • [43] Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
    Choi, Sujin
    Kim, Bo Kyung
    Ahn, Hong Yul
    Hong, Kyung Taek
    Choi, Jung Yoon
    Shin, Hee Young
    Kang, Hyoung Jin
    BLOOD RESEARCH, 2020, 55 (04) : 217 - 224
  • [44] Prognostic Impact of FLT3-ITD Mutational Burden and NPM1 Mutation in Normal Karyotype Acute Myeloid Leukemia Patients Undergoing HSCT
    Jiang, Gina
    Capo-Chichi, Jose-Mario
    Atenafu, Eshetu
    Minden, Mark
    Chang, Hong
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1315 - 1316
  • [45] Erratum: Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
    N I Noguera
    E Ammatuna
    D Zangrilli
    S Lavorgna
    M Divona
    F Buccisano
    S Amadori
    C Mecucci
    B Falini
    F Lo-Coco
    Leukemia, 2007, 21 (5) : 1135 - 1135
  • [46] The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia
    Yang, Jingyi
    Mo, Shanlan
    Wei, Xudong
    Lv, Xiaodong
    Fang, Baijun
    Zhang, Yanli
    Zhou, Jian
    Zhou, Hu
    Fu, Yuewen
    Lin, Quande
    Liu, Delong
    Song, Yongping
    Wang, Qianfei
    Zhou, Keshu
    BLOOD, 2023, 142
  • [47] Clinical importance of mutation types of FLT3-ITD in acute myeloid leukemia
    Kim, Seon Young
    Park, Yun Mi
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 551 - 551
  • [48] Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia
    Lam, Stephen S. Y.
    Ho, Eric S. K.
    He, Bai-Liang
    Wong, Wui-Wing
    Cher, Chae-Yin
    Ng, Nelson K. L.
    Man, Cheuk-Him
    Gill, Harinder
    Cheung, Alice M. S.
    Ip, Ho-Wan
    So, Chi-Chiu
    Tamburini, Jerome
    So, Chi Wai Eric
    Ho, Dona N.
    Au, Chun-Hang
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    Liang, Raymond
    Kwong, Yok-Lam
    Leung, Anskar Y. H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (359)
  • [49] Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia
    Smith, Catherine C.
    Chin, Jason
    Wang, Qi
    Salerno, Sara
    Damon, Lauren E.
    Hunt, Jeremy P.
    Levis, Mark J.
    Perl, Alexander E.
    Travers, Kevin
    Wang, Susana
    Kasarskis, Andrew
    Schadt, Eric
    Kuriyan, John
    Shah, Neil
    BLOOD, 2011, 118 (21) : 426 - 427
  • [50] FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favourable - or intermediate - risk
    Toylu, A.
    Karauzum, S.
    Akkaya, B.
    Salim, O.
    Undar, L.
    VIRCHOWS ARCHIV, 2017, 471 : S142 - S142
12345